| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | RETROPHIN INC COM | 158,100 | 1,856,000 | 0.71% | ||
| 2 | ACELRX PHARMACEUTICALS INC | 195,600 | 2,005,000 | 0.77% | ||
| 3 | RIGEL PHARMACEUTICAL INC | 923,200 | 3,352,000 | 1.28% | ||
| 4 | CORIUM INTERNATIONAL INC | 511,500 | 3,975,000 | 1.52% | ||
| 5 | FIVE PRIME THERAPEUTICS INC | 262,000 | 4,074,000 | 1.56% | ||
| 6 | Momenta Pharmaceuticals Inc | 384,900 | 4,649,000 | 1.78% | ||
| 7 | SAGENT PHARMACEUTICALS INC | 183,100 | 4,735,000 | 1.81% | ||
| 8 | KYTHERA BIOPHARMACEUTICALS I | 124,900 | 4,792,000 | 1.83% | ||
| 9 | XENOPORT INC | 1,172,700 | 5,664,000 | 2.16% | ||
| 10 | WELLCARE HEALTH PLANS INC COM | 79,100 | 5,906,000 | 2.26% | ||
| 11 | CARDINAL HEALTH INC | 95,700 | 6,562,000 | 2.51% | ||
| 12 | MAGELLAN HEALTH INC COM NEW | 108,200 | 6,735,000 | 2.57% | ||
| 13 | GLAXOSMITHKLINE PLC | 161,100 | 8,615,000 | 3.29% | ||
| 14 | Allergan plc | 51,900 | 8,782,000 | 3.35% | ||
| 15 | MEDTRONIC INC | 147,100 | 9,379,000 | 3.58% | ||
| 16 | Mylan Inc | 190,700 | 9,832,000 | 3.76% | ||
| 17 | ENANTA PHARMACEUTICALS INC COM | 255,128 | 10,988,000 | 4.20% | ||
| 18 | MEDIVATION INC | 166,834 | 12,859,000 | 4.91% | ||
| 19 | AMGEN INC | 119,298 | 14,121,000 | 5.39% | ||
| 20 | ORTHOFIX INTERNATIONAL NV | 390,898 | 14,170,000 | 5.41% | ||
| 21 | Questcor | 158,100 | 14,622,000 | 5.58% | ||
| 22 | INSMED INC COM PAR .01 | 818,700 | 16,358,000 | 6.25% | ||
| 23 | ABBVIE INC | 309,595 | 17,474,000 | 6.67% | ||
| 24 | COMMUNITY HEALTH SYS INC NEW COM | 421,400 | 19,119,000 | 7.30% | ||
| 25 | SANOFI | 478,600 | 25,447,000 | 9.72% | ||
| 26 | TEVA PHARMACEUTICAL INDS LTD | 490,996 | 25,739,000 | 9.83% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-14-000180, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
